Lighthouse Investment Partners LLC grew its stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 337.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 173,691 shares of the company's stock after purchasing an additional 134,010 shares during the quarter. Lighthouse Investment Partners LLC owned approximately 0.07% of Ryan Specialty worth $11,144,000 as of its most recent SEC filing.
Several other institutional investors have also modified their holdings of the stock. Mariner LLC lifted its stake in shares of Ryan Specialty by 3.4% in the fourth quarter. Mariner LLC now owns 5,278 shares of the company's stock worth $339,000 after buying an additional 172 shares in the last quarter. Sanctuary Advisors LLC lifted its stake in shares of Ryan Specialty by 1.2% in the fourth quarter. Sanctuary Advisors LLC now owns 15,690 shares of the company's stock worth $1,045,000 after buying an additional 188 shares in the last quarter. State of Alaska Department of Revenue lifted its stake in shares of Ryan Specialty by 1.6% in the fourth quarter. State of Alaska Department of Revenue now owns 12,130 shares of the company's stock worth $778,000 after buying an additional 190 shares in the last quarter. CIBC Asset Management Inc lifted its stake in shares of Ryan Specialty by 5.6% in the fourth quarter. CIBC Asset Management Inc now owns 3,674 shares of the company's stock worth $236,000 after buying an additional 196 shares in the last quarter. Finally, Treasurer of the State of North Carolina lifted its stake in shares of Ryan Specialty by 0.6% in the fourth quarter. Treasurer of the State of North Carolina now owns 44,990 shares of the company's stock worth $2,887,000 after buying an additional 280 shares in the last quarter. Institutional investors and hedge funds own 84.82% of the company's stock.
Ryan Specialty Trading Up 1.1%
Shares of Ryan Specialty stock traded up $0.80 on Friday, reaching $70.67. The company had a trading volume of 672,673 shares, compared to its average volume of 981,555. The firm's 50 day moving average price is $70.16 and its two-hundred day moving average price is $68.73. The firm has a market cap of $18.55 billion, a PE ratio of 102.42, a PEG ratio of 1.19 and a beta of 0.68. Ryan Specialty Holdings, Inc. has a 52-week low of $52.34 and a 52-week high of $77.16. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01.
Ryan Specialty (NYSE:RYAN - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The company reported $0.39 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.39. The business had revenue of $690.17 million for the quarter, compared to the consensus estimate of $680.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The business's revenue was up 25.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.35 EPS. Sell-side analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.
Ryan Specialty Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, May 27th. Stockholders of record on Tuesday, May 13th will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.68%. The ex-dividend date is Tuesday, May 13th. Ryan Specialty's dividend payout ratio (DPR) is 141.18%.
Insider Buying and Selling
In other Ryan Specialty news, EVP Brendan Martin Mulshine sold 30,000 shares of the business's stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 11.10% of the stock is owned by insiders.
Wall Street Analyst Weigh In
Several equities analysts have recently weighed in on RYAN shares. TD Cowen started coverage on shares of Ryan Specialty in a research note on Thursday, April 10th. They issued a "buy" rating and a $89.00 price target on the stock. Royal Bank of Canada decreased their price target on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a research note on Friday, February 21st. Keefe, Bruyette & Woods decreased their price target on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 9th. Barclays reduced their target price on shares of Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating on the stock in a research note on Friday, April 11th. Finally, UBS Group lifted their target price on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $76.42.
View Our Latest Report on RYAN
Ryan Specialty Profile
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Further Reading

Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.